Prkra Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Prkra Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Prkra Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@miller2019]
PRKRA (Protein Activator of Interferon Induced Protein Kinase), also known as PACT, is a key regulator of cellular stress responses, stress granule assembly, and antiviral immunity. [@cuccurazzu2018]
Protein Overview
Structure
Domain Architecture:
N-terminal dsRNA-binding Domain: Two dsRNA-binding motifs (dsRBMs)
Associates with Dicer in the microRNA processing pathway
Functions as a co-factor for RNA interference
Apoptosis Regulation:
Can promote or inhibit [apoptosis](/entities/apoptosis) depending on context
PKR-dependent and independent pathways
Role in Disease
ALS:
PRKRA mutations cause familial ALS
Mutant PACT forms abnormal stress granules
Disrupted stress granule dynamics lead to neuronal death
Impaired antiviral response may contribute to neurodegeneration
Dystonia:
DBM (dystonia with mitochondrial mutation) syndrome
Early-onset generalized dystonia with tremor
Mutations affect stress granule formation
Parkinson's Disease:
Dysregulated stress response pathways
Impaired stress granule dynamics
May contribute to [alpha-synuclein](/mechanisms/alpha-synuclein) pathology
Therapeutic Targeting
Stress Granule Modulators:
Antiviral Strategies:
Targeting PACT-PKR interaction for antiviral therapy
Understanding stress response in neurodegeneration
Overview
Prkra Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Prkra Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
[Related Topics](/index)
External Links
References
[Duty S, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20734298/)
[Miller C, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31358983/)
[Cuccurazzu B, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29530366/)
[Yount JS, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22226781/)
[Kim WJ, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18378691/)